Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression
Depression is a common comorbidity in Parkinson's disease (PD) but is underdiagnosed. We aim to investigate the altered metabolic pathways of Parkinson's disease-related depression (PDD) in plasma and to identify potential biomarkers for clinical diagnosis. Consecutive patients with PD wer...
Main Authors: | Mei-Xue Dong, Xia Feng, Xiao-Min Xu, Ling Hu, Yang Liu, Si-Yu Jia, Bo Li, Wei Chen, You-Dong Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2018.00257/full |
Similar Items
-
Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson’s Disease
by: Ling Hu, et al.
Published: (2020-06-01) -
Biomarker Research in Parkinson’s Disease Using Metabolite Profiling
by: Jesper F. Havelund, et al.
Published: (2017-08-01) -
Molecular biomarkers of endometriosis - options for non-invasive diagnostics?
by: Tea Lanišnik Rižner
Published: (2014-12-01) -
Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
by: Maike Sperk, et al.
Published: (2021-02-01) -
Omics-based biomarkers: current status and potential use in the clinic
by: Héctor Quezada, et al.
Published: (2017-05-01)